ID

42191

Description

Documentation part: Clinical evaluation & outcome evaluation A Randomised, Observer-blind, Multicentre, Non-inferiority, Comparative, Phase III Study of the Safety and Efficacy of Topical 1% SB-275833 Ointment, Applied Twice Daily for 5 Days, versus Topical 2% Sodium Fusidate Ointment Applied Three Times Daily for 7 Days in the Treatment of Adult and Paediatric Subjects with Impetigo. ClinicalTrials.gov Identifier: NCT00133874 Other Study ID Numbers: TOC100224 Responsible Party: GlaxoSmithKline

Mots-clés

  1. 27/06/2016 27/06/2016 -
  2. 13/04/2021 13/04/2021 - Dr. rer. medic Philipp Neuhaus
  3. 17/11/2021 17/11/2021 -
Téléchargé le

13 avril 2021

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Clinical evaluation & outcome evaluation Topical SB-275833 Ointment 1% For The Treatment Of Impetigo NCT00133874

Clinical evaluation & outcome evaluation Topical SB-275833 Ointment 1% For The Treatment Of Impetigo NCT00133874

Clinical Evaluation
Description

Clinical Evaluation

Clinical Evaluation
Description

Clinical Evaluation

Type de données

text

Alias
UMLS CUI [1]
C1261322
Withdrawal
Description

Withdrawal

Is the subject withdrawing from treatment at this visit?
Description

Is the subject withdrawing from treatment at this visit?

Type de données

text

Alias
UMLS CUI [1]
C0422727
Clinical outcome determination (OUT)
Description

Clinical outcome determination (OUT)

Clinical success
Description

Clinical success

Type de données

text

Alias
UMLS CUI [1]
C0085565
Clinical failure
Description

Clinical failure

Type de données

text

Alias
UMLS CUI [1]
C3640841
If "Yes", please specify if this was due to Primary or Secondary lesion:
Description

If "Yes", please specify if this was due to Primary or Secondary lesion:

Type de données

text

Alias
UMLS CUI [1,1]
C3640841
UMLS CUI [1,2]
| C1402294
UMLS CUI [2]
C1519215
Date of failure
Description

Date of failure

Type de données

date

Unités de mesure
  • DDMONYYYY
Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C3640841
DDMONYYYY
Unable to determine, please specify:
Description

Unable to determine, please specify:

Type de données

text

Alias
UMLS CUI [1,1]
C0085565
UMLS CUI [1,2]
C3845108

Similar models

Clinical evaluation & outcome evaluation Topical SB-275833 Ointment 1% For The Treatment Of Impetigo NCT00133874

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Clinical Evaluation
Item
Clinical Evaluation
text
C1261322 (UMLS CUI [1])
Code List
Clinical Evaluation
CL Item
Improvement (1)
CL Item
Worsening (2)
CL Item
No change (3)
Item Group
Withdrawal
Item
Is the subject withdrawing from treatment at this visit?
text
C0422727 (UMLS CUI [1])
Code List
Is the subject withdrawing from treatment at this visit?
CL Item
Yes (Y)
CL Item
No (N)
Item Group
Clinical outcome determination (OUT)
Item
Clinical success
text
C0085565 (UMLS CUI [1])
Code List
Clinical success
CL Item
Yes (Y)
CL Item
No (N)
Item
Clinical failure
text
C3640841 (UMLS CUI [1])
Code List
Clinical failure
CL Item
Yes (Y)
CL Item
No (N)
Item
If "Yes", please specify if this was due to Primary or Secondary lesion:
text
C3640841 (UMLS CUI [1,1])
| C1402294 (UMLS CUI [1,2])
C1519215 (UMLS CUI [2])
Code List
If "Yes", please specify if this was due to Primary or Secondary lesion:
CL Item
Primary lesion (P)
CL Item
Secondary lesion (S)
Date of failure
Item
Date of failure
date
C0011008 (UMLS CUI [1,1])
C3640841 (UMLS CUI [1,2])
Unable to determine, please specify:
Item
Unable to determine, please specify:
text
C0085565 (UMLS CUI [1,1])
C3845108 (UMLS CUI [1,2])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial